FDA OKs Philips Breast Cancer Risk Assessment Software; Phil Meyer Comments

PhilipsLogoThe Food and Drug Administration has approved a Royal Philips-built software application designed to evaluate breast density in women who undergo digital mammograms.

Philips’ Spectral Breast Density Measurement Application is intended to work with Philip’s MicroDose SI technology that is used for breast cancer screening, Philips said Thursday.

According to the company, the software works to compare the amounts of adipose and grandular tissues in the breast, then automatically correlate the resulting score to the BI-RADS breast density classification system.

Phil Meyer, Philips’ general manager and vice president for diagnostic X-ray and women’s health in North America, said the platform is built to help clinicians identify treatment methods for women with breast cancer.

The company designed the imaging app to meet state laws requiring health care providers to provide women with breast density information in mammogram reports.

email
Filed in: Healthcare IT, News Tags: , , , , , ,

You might like:

Verizon, Renfinity Forge Alliance to Help Users in Cloud Security; Renee McCown Comments Verizon, Renfinity Forge Alliance to Help Users in Cloud Security; Renee McCown Comments
Philips, Salesforce.com Alliance to Offer Healthcare Tech Platform; Marc Benioff Comments Philips, Salesforce.com Alliance to Offer Healthcare Tech Platform; Marc Benioff Comments
Razorsight Adds New Client for Analytics Offerings Razorsight Adds New Client for Analytics Offerings
Jeff Lovin: Woolpert Adds Google Maps Tech to Enterprise Geospatial Market Portfolio Jeff Lovin: Woolpert Adds Google Maps Tech to Enterprise Geospatial Market Portfolio

Leave a Reply

Submit Comment

© 2014 ExecutiveBiz. All rights reserved.